CN104208090B - A kind of preventing and treating Bovine Ephemeral Fever compositions - Google Patents

A kind of preventing and treating Bovine Ephemeral Fever compositions Download PDF

Info

Publication number
CN104208090B
CN104208090B CN201410476366.6A CN201410476366A CN104208090B CN 104208090 B CN104208090 B CN 104208090B CN 201410476366 A CN201410476366 A CN 201410476366A CN 104208090 B CN104208090 B CN 104208090B
Authority
CN
China
Prior art keywords
preventing
treating
cattle
ephemeral fever
bovine ephemeral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410476366.6A
Other languages
Chinese (zh)
Other versions
CN104208090A (en
Inventor
刘思当
岳瑞超
程子龙
屈亚锦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Agricultural University
Original Assignee
Shandong Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Agricultural University filed Critical Shandong Agricultural University
Priority to CN201410476366.6A priority Critical patent/CN104208090B/en
Publication of CN104208090A publication Critical patent/CN104208090A/en
Application granted granted Critical
Publication of CN104208090B publication Critical patent/CN104208090B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention relates to field of veterinary, particularly provide a kind of preventing and treating Bovine Ephemeral Fever compositions, said composition by carbasalate calcium, astragalus polysaccharides, be coated enrofloxacin, polygynax, be coated Vc and form.It is up to 97% with the average cure rate of the prescription medicine oral medication Bovine Ephemeral Fever case of the present invention, there is the advantages such as stable in properties, good palatability, long shelf-life.This prescription medicine and oral medication method have easy to use, without treating stress, need not the advantage such as professional veterinary technical staff, saving manpower, every medical expense suffering from cattle is made to significantly reduce, only the 1/3 of traditional therapy, and be conducive to suffering from the recovery of cattle production performance.Preventing and treating for Bovine Ephemeral Fever provides strong material and technical guarantee, and new thinking has been started in the preventing and treating for this disease simultaneously.

Description

A kind of preventing and treating Bovine Ephemeral Fever compositions
Technical field
The present invention relates to field of veterinary, particularly provide a kind of preventing and treating Bovine Ephemeral Fever compositions.
Background technology
Bovine Ephemeral Fever, also known as Ephemeral fever or temporarily hot, is the acute febrile infectious disease caused by bovine epizootic fever virus.This disease Mainly encroaching on cattle, wherein milch cow, cattle and Babalus bubalis L. are the most susceptible, and adult dairy cattle is in a bad way than young milch cow, give milk in early days and in The milch cow of phase is even more serious than the cattle of dry milk phase.Primary disease is periodic epidemic, and general interval occurs the most fairly large in 3~4 years Popular, occur the most year after year, occur more with summer, mosquito active phase in autumn, many rainy seasons that especially weather is sultry or round the clock The weather that the temperature difference is bigger easily causes popular.This disease is popular extensively, and spread speed is fast, and sickness rate is high, big on production performance impact, leads Cause part sick cattle paralysis and eliminated or dead because of secondary other diseases, cause serious economic loss can to morbidity cattle farm. Cardinal symptom is sudden onset, high heat, shed tears, watery nasal discharge, rapid breathing, sialorrhea with foam, hind leg walking is dumb even Not rising, the sick cattle of major part can recover normal, how in optimum process through the heating of 3-4 days sleepingly.In uncomplicated situation Lower case fatality rate is generally not more than 2%~3%.But some feeding and management is improper or the morbidity cattle farm mortality rate treated in time Higher.Such as the Bovine Ephemeral Fever of Shandong outburst autumn in 2013, the death rate in many cattle farms is more than 10%, and milk yield reduces More than 60%, cause great economic loss to cattle farm.
The base therapy principle of this disease be antipyretic-antalgic, preventing and treating secondary infection, heart tonifying, fluid infusion, correction acid base imbalance, Relieving asthma, oxygenating etc..Traditional Therapeutic Method is mainly by venous transfusion or intramuscular injection.Process by traditional therapy, cattle Field needs the veterinary technician of specialty and a large amount of paraprofessional personnel.It addition, what ill cattle needed most is quiet rest, forbidding stress Stimulate, and traditional Therapeutic Method, because for the treatment of cattle is carried out arrest, Baoding, injection can cause the fear of cattle, struggle, ouch, Shying group thus cause serious stress, serious harm disease cattle and the health of whole cows are often made the state of an illness add further by this Weight;And existing additive method and medicine to this disease all without good therapeutic effect, therefore need badly exploitation a kind of brand-new for The medicine of this disease treatment.
Summary of the invention
Based on above-mentioned reason, the present inventor provides a kind of preventing and treating Bovine Ephemeral Fever compositions, said composition by Carbasalate calcium, astragalus polysaccharides, be coated enrofloxacin, polygynax, be coated Vc composition.It is administered orally with the prescription medicine of the present invention The treatment average cure rate of Bovine Ephemeral Fever case is up to 97%, and this prescription medicine has stable in properties, good palatability, long shelf-life etc. Advantage.This prescription medicine can directly be drunk water or spice is taken, and has easy to use, without treating stress, need not specialty beast The advantages such as doctor technical staff, saving manpower, can make every medical expense suffering from cattle significantly reduce, only the 1/ of traditional therapy 3, and be conducive to suffering from the recovery of cattle production performance.Preventing and treating for Bovine Ephemeral Fever provides strong material and technical guarantee, simultaneously New thinking has been started in preventing and treating for this disease.
The concrete technical scheme of the present invention is:
The key component of preventing and treating Bovine Ephemeral Fever compositions is calculated as by weight:
Above-mentioned all ingredients belong to the conventional products in veterinary drug market, directly can buy on veterinary drug market.
Described carbasalate calcium soluble powder, have antipyretic, analgesia, antiinflammatory triple effect unification effect, be that European Union is unique Approval is for the oral antipyretic analgesic of poultry;This medicine drinking-water or spice good absorbing, instant effect, without any untoward reaction.
Described astragalus polysaccharides is that the dry root of leguminous plant Radix Astagali or Radix Astragali is extracted, concentrate, purification and The water solublity heteropolysaccharide become, can have the effects such as antiviral, anti-stress, antioxidation as immunopotentiating agent or regulator simultaneously;
The described enrofloxacin that is coated is animal specific fluoroquinolones, has that has a broad antifungal spectrum, bactericidal activity be strong, body In widely distributed, the feature such as have no side effect, and has good in terms of prevention and treatment animal bacteria epidemic disease and mycoplasma infection Good effect.But due to the bitterness of enrofloxacin self, clinical practice is extremely restricted.Of the present invention it is coated En Nuo Sha Xing (production of Zhengzhou Fu Yuan pharmaceutcal corporation, Ltd) uses lipid microcapsule body dispersion technology, and enrofloxacin is completely enclosed in lipoid In matter bimolecular, bitterness disappears and will not be destroyed drug effect by gastric environment and not destroy cud microecological environment, treats that medicine enters machine After body, carrier decomposes under the effect of intestinal fat enzyme, thus discharges medicine, plays curative effect;
Described polygynax is aminoglycoside antibiotics, to intestinal such as escherichia coli, Salmonella, Proteus Bacteriaceae antibacterial has good antibacterial action, oral after major part is the most varied discharges with feces, oral can prevent and treat Bovine Ephemeral Fever and continue The gastroenteritis sent out;
The described Vc that is coated, also known as ascorbic acid, is a kind of extremely strong reducing agent, free-radical antagonists.There is promotion tissue Injury repairing, reduces blood vessel and oozes out, prevent hemorrhage;Enhancing human body immunity power and anti-stress ability;Participate in various kinds of cell metabolism Journey.So, vitamin C has the highest using value in terms of antiviral and preventing viral infectious disease.But Vc is making moist, is meeting Instability under heat, acid, alkali or illumination, is particularly present Cu2+、Fe3+Under the conditions of plasma or ascorbic acid oxidase etc. oxidizable point Solve.The Vc of being coated of the present invention (Anhui Tiger Biotechnology Co., Ltd.'s production) is by common vitamin C warp Cross Crushing of Ultrafine, micro-bonding, add microcapsule, micro-technology such as be coated carries out microcapsule, micro-is coated process.Be coated Vc can high temperature resistant, wet, Heat, mineral, acid, alkali, extruding etc., it is simple to and other medicines collocation, pass through cattle stomach and absorb at small intestinal epimere.
Carbasalate calcium soluble powder belongs to the medicine and have anti-stress effect of inducing sweat of quick acting;Astragalus polysaccharides is wide spectrum Anti virus herb extract;Enrofloxacin cures mainly the antibacterial secondary infection of respiratory tract, and neomycin cures mainly gastral antibacterial and continues Sending out and infect, two kinds of antibacterials have identical antibacterial action;Vc in scavenging activated oxygen, removing toxic substances and protective tissue from damage etc. Aspect plays pivotal role.Above-mentioned 5 kinds of ingredients are in antipyretic, anti-stress, antiviral, bacteriological protection secondary infection, enhancing body The aspects such as resistance act in accordance with the division of their functions and duties, and effect is complementary, collaborative disease-resistant, is used in mixed way without any untoward reaction.This prescription and treatment side Method has fully demonstrated the contemporary disease treatment theory for the treatment of both the principal and secondary aspects of a disease, the combination of Chinese and Western medicine, emphasis animal welfare.
Component is optimized and repetition test by inventor, is finally obtained a kind of preventing and treating Bovine Ephemeral Fever compositions, its Key component is calculated as by weight:
In the case of above-mentioned consumption, the therapeutic effect for Bovine Ephemeral Fever is optimal, and substantially has no side effect;
Time specifically used, can by aforementioned pharmaceutical compositions according to the consumption that a weight portion is 75mg/kg Niu Tichong by group Compound directly stir after spice or add Direct-fed in drinking-water to.
The pharmaceutical composition of the present invention is than traditional treatment Bovine Ephemeral Fever medicine, and cure rate is higher, can reach 97% with On, and there is not toxic and side effects, do not result in impact especially for giving milk of milch cow, in addition, due to whole combination yet The medicine of thing is the veterinary drug raw material that China allows to use, and with low cost, whole treatment cost is only the three of traditional therapy / mono-less than, can be in China's popularization and application widely.
In sum, the average cure rate of the prescription medicine oral medication Niu Liuhang case of the present invention is used to be up to 97%, There is the advantages such as stable in properties, good palatability, long shelf-life, and Integrated TCM, there is antipyretic-antalgic, antiviral, bacteriological protection Drug effect, this prescription medicine and the oral medication methods such as secondary infection, enhancing body resistance have easy to use can directly drink water Or spice is taken, nothing treats stress, need not professional veterinary technical staff, save the advantages such as manpower, makes every to suffer from cattle Medical expense significantly reduces, only the 1/3 of traditional therapy, and is conducive to suffering from the recovery of cattle production performance;For Bovine Ephemeral Fever Preventing and treating provide strong material and technical guarantee, new thinking has been started in the preventing and treating for this disease simultaneously.
Detailed description of the invention
Below by specific embodiment, the present invention is further illustrated.
Embodiment 1:
Preventing and treating Bovine Ephemeral Fever compositions, its key component is calculated as by weight:
Embodiment 2:
Preventing and treating Bovine Ephemeral Fever compositions, its key component is calculated as by weight:
Embodiment 3:
Preventing and treating Bovine Ephemeral Fever compositions, its key component is calculated as by weight:
Embodiment 4:
Preventing and treating Bovine Ephemeral Fever compositions, its key component is calculated as by weight:
Experimental example 5
Choosing three large-scale milch cow farms that Bovine Ephemeral Fever occurs and carry out contrast test, the most ill milch cow is equally divided into two Group, one group uses traditional therapy treatment, one group of compositions using the present invention directly to drink water or spice oral medication, its In:
Traditional therapy is:
(1) antipyretic-antalgic: intramuscular injection 30% dipyrone 30 milliliters, 1~2 times/day.
(2) for the secondary infection of prevention pulmonary, intramuscular injection penicillin 5,600,000 IU, streptomycin 3,000,000 microgram add glucose 1500 milliliters of medium-sized vein injections of saline, 2 times/day.
(3) analgesia, heart tonifying, fluid infusion, removing toxic substances.Walk lamely and paralysis cattle can intravenous injection sodium salicylate 200 milliliters, to alleviate pain Pain and relief of symptoms;The person of having a weak heart can 40 milliliters, 50 milliliters vitamin Cs of intravenous injection caffeine and sodium benzoate and low molecular dextran 1000 milliliters.
(4) sleepingly do not rise, head and neck lateral bending person can intravenous injection 10% glucose 1500 milliliters, 5% calcium bromide 200 milliliters and VITAMIN B15 0 milliliter;Rear quarters is stiff or hindlimb paralysis person's intramuscular injection Rhizoma Corydalis Decumbentis 40 milliliters, 2 times/day.
The compositions Therapeutic Method of the present invention is: according to suffering from Niu Tichong calculating consumption: compositions soluble powder 75mg/kg body Weight, directly drinking-water or spice are administered orally, and 2 times/day, are used in conjunction 3~5;
Final therapeutic effect see table
Table 1 raising dairy cattle field A (breeding milk cow 160)
Therapeutic Method Sick cattle number (head) Cure rate Average cure time Treatment cost/head
Oral medication 32 97% (31/32) 3.5 my god 35.7 yuan
Traditional treatment 32 97% (31/32) 3.7 my god 111.0 it is first
Table 2 raising dairy cattle field B (breeding milk cow 210)
Therapeutic Method Sick cattle number (head) Cure rate Average cure time Treatment cost/head
Oral medication 35 97% (34/35) 4 days 40.3 yuan
Traditional treatment 35 94% (33/35) 3.6 108.4 it is first
Table 3 raising dairy cattle field C (breeding milk cow 150)
Therapeutic Method Sick cattle number (head) Cure rate Average cure time Treatment cost/head
Oral medication 27 100% (27/27) 4 days 40.5 yuan
Traditional treatment 27 96% (26/27) 3.8 my god 114.8 it is first
The therapeutic effect of relatively 3 test cattle farms is it can be seen that the average cure rate of oral medication group of 3 cattle farms is above 97%, the average cure rate of traditional treatment group is then less than 97%, it is seen that the therapeutic effect of the present composition is controlled higher than tradition Treatment method;
The average cure time of 3 cattle farms 3.8 days, wherein oral medication group 3.9 days, traditional treatment group 3.7 days, without substantially Difference;
Average every sick cattle of 3 cattle farms control average 75 yuan for the treatment of cost, wherein oral medication group averagely every 38.8 yuan, Traditional treatment group 111.1 yuan, the average expenses for medicine of traditional treatment group is 2.9 times of oral medication group, it is seen that the treatment of the present invention becomes This detail is less than traditional therapy.It addition, oral medication group recovers the milk yield of cattle also apparently higher than traditional treatment group.

Claims (2)

1. a preventing and treating Bovine Ephemeral Fever compositions, it is characterised in that: its component is calculated as by weight:
Compositions the most according to claim 1, it is characterised in that: its component is calculated as by weight:
CN201410476366.6A 2014-09-18 2014-09-18 A kind of preventing and treating Bovine Ephemeral Fever compositions Expired - Fee Related CN104208090B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410476366.6A CN104208090B (en) 2014-09-18 2014-09-18 A kind of preventing and treating Bovine Ephemeral Fever compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410476366.6A CN104208090B (en) 2014-09-18 2014-09-18 A kind of preventing and treating Bovine Ephemeral Fever compositions

Publications (2)

Publication Number Publication Date
CN104208090A CN104208090A (en) 2014-12-17
CN104208090B true CN104208090B (en) 2016-08-17

Family

ID=52090264

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410476366.6A Expired - Fee Related CN104208090B (en) 2014-09-18 2014-09-18 A kind of preventing and treating Bovine Ephemeral Fever compositions

Country Status (1)

Country Link
CN (1) CN104208090B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101829285A (en) * 2010-03-30 2010-09-15 张小栋 Medicament formula of traditional Chinese medicine for treating bovine ephemeral fever and application method thereof
CN102784219A (en) * 2012-08-01 2012-11-21 青岛绿曼生物工程有限公司 Compound pure Chinese medicine composition for treating bovine ephemeral fever and preparation method of same
CN103054984A (en) * 2011-10-21 2013-04-24 董根荣 Chinese veterinary medicinal granules for preventing bovine epizootic fever and preparation method of granules

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101829285A (en) * 2010-03-30 2010-09-15 张小栋 Medicament formula of traditional Chinese medicine for treating bovine ephemeral fever and application method thereof
CN103054984A (en) * 2011-10-21 2013-04-24 董根荣 Chinese veterinary medicinal granules for preventing bovine epizootic fever and preparation method of granules
CN102784219A (en) * 2012-08-01 2012-11-21 青岛绿曼生物工程有限公司 Compound pure Chinese medicine composition for treating bovine ephemeral fever and preparation method of same

Also Published As

Publication number Publication date
CN104208090A (en) 2014-12-17

Similar Documents

Publication Publication Date Title
CN102772478B (en) Traditional Chinese medicine granule for enhancing immunity of livestock and poultry
CN103719609B (en) Feed for lactating sows and preparation method thereof
CN103006892A (en) Medicine composition for preventing and treating porcine viral diseases, and premix and batch with composition
CN104001095A (en) Traditional Chinese medicine (TCM) composition for treating diarrhea
CN102698158B (en) Traditional Chinese medicine for preventing and treating infectious bronchitis, preparation method thereof and feed
CN104208090B (en) A kind of preventing and treating Bovine Ephemeral Fever compositions
CN107812166A (en) A kind of feed addictive for preventing fish acute gastroenteritis and preparation method thereof
CN103861007B (en) A kind of Chinese herbal compound preparation for the treatment of chicken diarrhea
CN111905034A (en) Traditional Chinese medicine composition for preventing and treating African swine fever and preparation method thereof
CN104887945B (en) It is a kind of to be used to treat Chinese medicine composition of lamb pneumonia and its preparation method and application
CN104399049A (en) Traditional Chinese medicine mixture for treating cold type asthma
CN104208653A (en) Traditional Chinese medicine composition for treating piglet yellow-white dysentery and preparation method for same
CN110201098A (en) A kind of compound bee-glue composition and the preparation method and application thereof for treating animal dysentery
CN105688171B (en) Feed additive for chicks and preparation method thereof
CN107929514B (en) Traditional Chinese medicine composition for treating postpartum constipation of sow and preparation method and application thereof
CN101664466A (en) Traditional Chinese herbal composition for treating pyretic pulmonary disease of animals and preparation method thereof
CN104857496B (en) A kind of Chinese traditional medicine navel for the treatment of children's's wind-cold type diarrhoea pastes
CN105832714B (en) Application of taurine in preventing and/or treating diseases caused by coronavirus and/or rotavirus viruses
CN106728505A (en) A kind of Chinese medicine composition for treating pig founder
CN107050395B (en) Traditional Chinese medicine sigmoid colon instillation preparation for treating infantile exogenous fever and preparation method and application thereof
CN105031025A (en) Traditional Chinese medicine compound preparation for treating swine mycoplasmal pneumonia and preparation method thereof
CN105412803B (en) The pharmaceutical composition and preparation method thereof for treating poultry proventriculitis
CN104001137A (en) Traditional Chinese medicine (TCM) composition for treating diarrhea
CN117752761A (en) Pharmaceutical composition for treating bovine forestomach atony, preparation method and preparation thereof
CN104258361A (en) Traditional Chinese medicine composition for treating infantile asthma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160817

Termination date: 20170918

CF01 Termination of patent right due to non-payment of annual fee